Neurohormones as markers of right- and left-sided cardiac dimensions and function in patients with untreated chronic heart failure
Authors:
- Andreas KjærAndreas Kjær
- Per HildebrandtPHPer Hildebrandt
- Jon AppelJAJon Appel
- Claus Leth PetersenCPClaus Leth Petersen
- 18 March 2005
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 99 (2) , 301-306
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Comprehensive Guidelines for the Diagnosis and Treatment of Chronic Heart Failure Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of CardiologyEuropean Journal of Heart Failure, 2002
- Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectivesClinical Physiology and Functional Imaging, 2001
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF)The Lancet, 1999
- Incidence and aetiology of heart failure; a population-based studyEuropean Heart Journal, 1999
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trialThe Lancet, 1999
- Biochemical detection of left-ventricular systolic dysfunctionThe Lancet, 1998
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureNew England Journal of Medicine, 1991
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987